Fig. 3From: Safety and efficacy of the choline analogue SAR97276 for malaria treatment: results of two phase 2, open-label, multicenter trials in African patientsKaplan Meier estimates of a the 50% parasite reduction and b the 90% parasite reduction (Study 1). Group 1A: 1 day IM to adults; Group 1B: 3 days IM to adults; Group 1C: 1 day IV to adults, Group 1D: 3 days IM to childrenBack to article page